About 200 reports

  • undisclosed chemotherapy, topotecan hydrochloride, melphalan, filgrastim, busulfan and autologous hematopoietic stem cells alone or in combination have the highest number of nonseminomatous testicular cancer ongoing clinical trials.

Nonseminomatous Testicular Cancer Global Clinical Trials Review, H1, 2018 Summary GlobalData’s clinical trial report, “Nonseminomatous Testicular Cancer Global Clinical Trials Review, H1, 2018" provides an overview of Nonseminomatous Testicular Cancer clinical trials scenario.This report provides...

  • Cell Therapy
  • Chemotherapy
  • Therapy
  • World
  • Product Initiative
  • Target
  • Clinical Trial profile. 148 Trial Title

Leukocyte Disorders (White Blood Cell Disorders) Global Clinical Trials Review, H2, 2017 Summary GlobalData’s clinical trial report, “Leukocyte Disorders (White Blood Cell Disorders) Global Clinical Trials Review, H2, 2017" provides an overview of Leukocyte Disorders (White Blood Cell Disorders)...

  • Blood Disease
  • Cell Therapy
  • Chemotherapy
  • Clinical Trial
  • World

You can easily book an appointment with one online.

  • Cell Therapy
  • World
  • Forecast
  • Merck & Co., Inc.
  • Sanofi S.A.
  • Therapy Area Indication(s)

Hematological Tumor Global Clinical Trials Review, H2, 2017 Summary GlobalData’s clinical trial report, “Hematological Tumor Global Clinical Trials Review, H2, 2017" provides an overview of Hematological Tumor clinical trials scenario. This report provides top line data relating to the clinical trials on Hematological...

  • Cancer
  • Cell Therapy
  • Clinical Trial
  • World
  • Product Initiative
  • FILGRASTIM - DRUG PROFILE

Stroke - Pipeline Review, H2 2017 Summary Global Markets Direct’s latest Pharmaceutical and Healthcare disease pipeline guide Stroke - Pipeline Review, H2 2017, provides an overview of the Stroke (Cardiovascular) pipeline landscape. Stroke is a condition in which the brain cells suddenly die because of a lack...

  • Cell Therapy
  • Pharmaceutical
  • Stroke
  • Therapy
  • Athersys, Inc.

## ## ## ## ## ## ## ## Jazz Pharmaceuticals Plc ## ## ## ## ## ## ## ## Takeda Pharmaceutical Co Ltd ## ## ## ## ## ## ## ## Sanofi ## ## ## ## ## ## ## ## Pfizer Inc ## ## ## ## ## ## ## ## Bristol-Myers Squibb Co ## ## ## ## ## ## ## ## AbbVie Inc ## ## ## ## ##

  • Cancer
  • Cell Therapy
  • Clinical Trial
  • World
  • Product Initiative
  • Clinical Trial profile. 172 Trial Title
  • Clinical Trial profile. 283 Trial Title

The prominent features of this report are - ##.

  • Cell Therapy
  • Leukemia
  • Monoclonal Antibody
  • United States
  • World
  • Clinical Trial profile. 51 Trial Title
  • Clinical Trial profile. 53 Trial Title

## ## ## ## Merck & Co Inc ## ## ## ## ## Groupe Francophone des Myelodysplasies ## ## ## ## ## Daiichi Sankyo Co Ltd ## ## ## ## ## CTI BioPharma Corp ## ## ## ## ## Celerion Inc ## ## ## ## ## Bristol-Myers Squibb C

  • Cell Therapy
  • Therapy
  • World
  • Product Initiative
  • Celgene Corporation

Monday, April ##, ##:##-##:## p. m.

  • Cancer
  • Cell Therapy
  • Clinical Trial
  • World
  • Product Initiative
  • Clinical Trial profile. 729 Trial Title
  • Clinical Trial profile. 626 Trial Title

The prominent features of this report are - ##.

  • Cell Therapy
  • Clinical Trial
  • Oncology
  • World
  • Celgene Corporation

The prominent features of this report are - ##.

  • Cell Therapy
  • Lymphoma
  • United States
  • World
  • Product Initiative
  • Clinical Trial profile. 294 Trial Title
  • Clinical Trial profile. 375 Trial Title

Hoffmann-La Roche Ltd ## ## ## ## ## ## ## ## Progenics Pharmaceuticals Inc ## ## ## ## ## ## ## ## United Therapeutics Corp ## ## ## ## ## ## ## ## Novartis AG ## ## ## ## ## ## ## ## APEIRON Biologics AG ## ## ## ## ## ## ## ## Pfizer Inc ## ## ## ## ## ## ## ## Y-mAbs Therapeutics Inc ##

  • Cell Therapy
  • Clinical Trial
  • Oncology
  • World
  • Progenics Pharmaceuticals, Inc.
  • Clinical Trial profile. 161 Trial Title
  • 5. All the trials included are unique trials.

## ## ## ## ## ## Germany ## ## ## ## ## ## ## ## Japan ## ## ## ## ## ## ## ## United Kingdom ## ## ## ## ## ## ## ## France ## ## ## ## ## ## ## ## Italy ## ## ## ## ## ## ## ## Canada Source: GlobalData' s Phar

  • Blood Disease
  • Cell Therapy
  • General Medicine And Specialty Medicine
  • World
  • Product Initiative

The prominent features of this report are - ##.

  • Cell Therapy
  • Clinical Trial
  • Leukemia
  • Therapy
  • Novartis AG
  • R&D Progress

NA : Not Available Source: Global Markets Direct DRUGS TO INHIBIT SIRT## FOR ISCHEMIC STROKE AND MYOCARDIAL INFARCTION - DRUG PROFILE DS-## - DRUG PROFILE EP-## - DRUG PROFILE EPGN-## - DRUG PROFILE EPOETIN ALFA - DRUG PROFILE FILGRASTIM - DRUG PROFILE Drug Name Company/ Institute

  • Cell Therapy
  • Neurological Disorder
  • United States
  • Company
  • Product Initiative

The prominent features of this report are - ##.

  • Cancer
  • Cell Therapy
  • Therapy
  • World
  • Eli Lilly & Co.
  • Clinical Trial profile. 24 Trial Title

The prominent features of this report are - ##.

  • Cancer
  • Cell Therapy
  • Clinical Trial
  • United States
  • World
  • Clinical Trial profile. 779 Trial Title
  • CLINICAL TRIAL PROFILE. 971 TRIAL TITLE

The prominent features of this report are - ##.

  • Cancer
  • Cell Therapy
  • Clinical Trial
  • Ovarian Cancer
  • World
  • Clinical Trial profile. 247 Trial Title

Aplastic Anemia Global Clinical Trials Review, H1, 2017 Summary GlobalData’s clinical trial report, “Aplastic Anemia Global Clinical Trials Review, H1, 2017" provides an overview of Aplastic Anemia clinical trials scenario. This report provides top line data relating to the clinical trials on Aplastic Anemia. Report...

  • Blood Disease
  • Cell Therapy
  • World
  • Product Initiative
  • Novartis AG

## ## ## Merck & Co Inc ## ## ## ## ## ## AstraZeneca Plc ## ## ## ## ## ## Eli Lilly and Co ## ## ## ## ## ## GlaxoSmithKline Plc ## ## ## ## ## ## Novartis AG ## ## ## ## ## ## Pfizer Inc ## ## ## ## ## ## Italian Sarcoma Group ## ## ##

  • Cell Therapy
  • Clinical Trial
  • Monoclonal Antibody
  • World
  • Product Initiative
  • Clinical Trial profile. 61 Trial Title

The prominent features of this report are - ##.

  • Blood Disease
  • Cell Therapy
  • Leukemia
  • World
  • Product Initiative

Day ## must start in AM.

  • Blood Disease
  • Cell Therapy
  • Therapy
  • United States
  • Product Initiative

The prominent features of this report are - ##.

  • Cell Therapy
  • Clinical Trial
  • Neurology
  • World
  • Product Initiative

The prominent features of this report are - ##.

  • Cancer
  • Cell Therapy
  • Clinical Trial
  • Leukemia
  • Novartis AG

Its biosimilars products comprise PEG-filgrastim, teriparatide, somatropin, filgrastim, platelet-derived growth factor-BB, epidermal growth factor and glucagon.

  • Cell Therapy
  • Chronic Disease
  • Type 2 Diabetes
  • Wound Care
  • ProMetic Life Sciences Inc.
  • Clinical Trial profile. 228 Trial Title

## ## ## ## ## ## Russia ## ## ## ## ## ## ## Turkey ## ## ## ## ## ## ## Brazil ## ## ## ## ## ## ## Mexico ## ## ## ## ## ## ## India ## ## ## ## ## ## ## Source: GlobalData' s Pharma Intelligence Center Clin

  • Cell Therapy
  • Lymphoma
  • Therapy
  • World
  • Product Initiative
  • FILGRASTIM - DRUG PROFILE

Human Immunodeficiency Virus (HIV) Infections (AIDS) - Pipeline Review, H2 2017 Summary Global Markets Direct’s latest Pharmaceutical and Healthcare disease pipeline guide Human Immunodeficiency Virus (HIV) Infections (AIDS) - Pipeline Review, H2 2017, provides an overview of the Human Immunodeficiency...

  • Cell Therapy
  • HIV AIDS
  • Pathology
  • Vaccine
  • Merck & Co., Inc.

Hoffmann-La Roche Ltd ## ## ## ## ## GlaxoSmithKline Plc ## ## ## ## ## Wuhan Bio-Raid Biotechnology Co Ltd ## ## ## ## ## TG Therapeutics Inc ## ## ## ## ## Merck & Co Inc ## ## ## ## ## Incyte Corp ## ## ## ## ## BeiGene Ltd ## ## ## ## ## Astellas

  • Cell Therapy
  • Leukemia
  • Therapy
  • World
  • Product Initiative

Hoffmann-La Roche Ltd ## ## ## ## ## ## ## ## ## Bayer AG ## ## ## ## ## ## ## ## ## Merck & Co Inc ## ## ## ## ## ## ## ## ## Amgen Inc ## ## ## ## ## ## ## ## ## Pfizer Inc ## ## ## ## ## ## ## ## ## Takeda Pharmaceutical Company Ltd ## ## ## ## ## ## ## ## ## AstraZeneca Plc ## ## ## ##

  • Cancer
  • Cell Therapy
  • Clinical Trial
  • Oncology
  • Novartis AG
  • Clinical Trial profile. 2315 Trial Title
  • Clinical Trial profile. 645 Trial Title

One MDS patient experienced a PR.

  • Cell Therapy
  • Leukemia
  • Monoclonal Antibody
  • Pharmaceutical
  • World